𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sensitivity of EQ-5D to clinical change in patients with parkinson’s disease L-dopa induced dyskinesia

✍ Scribed by Petrillo, J.; Pendergraft, T.; Sacco, P.; Michalopoulos, S.; Oster, G.


Book ID
122920667
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
71 KB
Volume
16
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Idazoxan, an alpha-2 antagonist, and L-D
✍ O. Rascol; I. Arnulf; H. Peyro-Saint Paul; C. Brefel-Courbon; M. Vidailhet; C. T 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

## Abstract Dyskinesia is a frequent and disabling side effect in patients with Parkinson's disease treated with chronic dopatherapy. Preclinical data in the 1‐methyl‐4‐phenyl‐1,2,3,6,‐tetrahydropyridine (MPTP) monkey suggest that alpha‐2 antagonists may reduce dihydroxyphenylalanine (L‐DOPA)‐induc